183 related articles for article (PubMed ID: 28419207)
1. CKII-SIRT1-SM22α loop evokes a self-limited inflammatory response in vascular smooth muscle cells.
Shu YN; Dong LH; Li H; Pei QQ; Miao SB; Zhang F; Zhang DD; Chen R; Yin YJ; Lin YL; Xue ZY; Lv P; Xie XL; Zhao LL; Nie X; Chen P; Han M
Cardiovasc Res; 2017 Aug; 113(10):1198-1207. PubMed ID: 28419207
[TBL] [Abstract][Full Text] [Related]
2. SM22α inhibits vascular inflammation via stabilization of IκBα in vascular smooth muscle cells.
Shu YN; Zhang F; Bi W; Dong LH; Zhang DD; Chen R; Lv P; Xie XL; Lin YL; Xue ZY; Li H; Miao SB; Zhao LL; Wang H; Han M
J Mol Cell Cardiol; 2015 Jul; 84():191-9. PubMed ID: 25937534
[TBL] [Abstract][Full Text] [Related]
3. TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.
Dong LH; Li L; Song Y; Duan ZL; Sun SG; Lin YL; Miao SB; Yin YJ; Shu YN; Li H; Chen P; Zhao LL; Han M
Circ Res; 2015 Sep; 117(8):684-94. PubMed ID: 26291555
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo.
Lv P; Miao SB; Shu YN; Dong LH; Liu G; Xie XL; Gao M; Wang YC; Yin YJ; Wang XJ; Han M
Circ Res; 2012 Aug; 111(6):697-707. PubMed ID: 22798525
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 promotes the vascular smooth muscle cell re-differentiation through AMPK/SIRT1/FOXO3a signaling pathways.
Liu Z; Zhang M; Zhou T; Shen Q; Qin X
Atherosclerosis; 2018 Sep; 276():58-66. PubMed ID: 30036742
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.
Furgeson SB; Simpson PA; Park I; Vanputten V; Horita H; Kontos CD; Nemenoff RA; Weiser-Evans MC
Cardiovasc Res; 2010 May; 86(2):274-82. PubMed ID: 20051384
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
[TBL] [Abstract][Full Text] [Related]
8. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome profiling reveals that the SM22α-regulated molecular pathways contribute to vascular pathology.
Chen R; Zhang F; Song L; Shu Y; Lin Y; Dong L; Nie X; Zhang D; Chen P; Han M
J Mol Cell Cardiol; 2014 Jul; 72():263-72. PubMed ID: 24735829
[TBL] [Abstract][Full Text] [Related]
10. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC
Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways.
Sun JY; Li C; Shen ZX; Zhang WC; Ai TJ; Du LJ; Zhang YY; Yao GF; Liu Y; Sun S; Naray-Fejes-Toth A; Fejes-Toth G; Peng Y; Chen M; Liu X; Tao J; Zhou B; Yu Y; Guo F; Du J; Duan SZ
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):874-85. PubMed ID: 26966277
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
Chen J; Zhang J; Yang J; Xu L; Hu Q; Xu C; Yang S; Jiang H
Atherosclerosis; 2017 Feb; 257():152-163. PubMed ID: 28135625
[TBL] [Abstract][Full Text] [Related]
13. Insulin-independent GLUT4 translocation in proliferative vascular smooth muscle cells involves SM22α.
Zhao LL; Zhang F; Chen P; Xie XL; Dou YQ; Lin YL; Nie L; Lv P; Zhang DD; Li XK; Miao SB; Yin YJ; Dong LH; Song Y; Shu YN; Han M
J Mol Med (Berl); 2017 Feb; 95(2):181-192. PubMed ID: 27631639
[TBL] [Abstract][Full Text] [Related]
14. Disruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation.
Shen J; Yang M; Ju D; Jiang H; Zheng JP; Xu Z; Li L
Circ Res; 2010 Apr; 106(8):1351-62. PubMed ID: 20224039
[TBL] [Abstract][Full Text] [Related]
15. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
16. circ-Sirt1 controls NF-κB activation via sequence-specific interaction and enhancement of SIRT1 expression by binding to miR-132/212 in vascular smooth muscle cells.
Kong P; Yu Y; Wang L; Dou YQ; Zhang XH; Cui Y; Wang HY; Yong YT; Liu YB; Hu HJ; Cui W; Sun SG; Li BH; Zhang F; Han M
Nucleic Acids Res; 2019 Apr; 47(7):3580-3593. PubMed ID: 30820544
[TBL] [Abstract][Full Text] [Related]
17. Arterial injury promotes medial chondrogenesis in Sm22 knockout mice.
Shen J; Yang M; Jiang H; Ju D; Zheng JP; Xu Z; Liao TD; Li L
Cardiovasc Res; 2011 Apr; 90(1):28-37. PubMed ID: 21183509
[TBL] [Abstract][Full Text] [Related]
18. Thymine DNA glycosylase is a key regulator of CaMKIIγ expression and vascular smooth muscle phenotype.
Liu Y; Sun LY; Singer DV; Ginnan R; Zhao W; Jourd'heuil FL; Jourd'heuil D; Long X; Singer HA
Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H969-H980. PubMed ID: 31518169
[TBL] [Abstract][Full Text] [Related]
19. Smooth muscle 22α facilitates angiotensin II-induced signaling and vascular contraction.
Xie XL; Nie X; Wu J; Zhang F; Zhao LL; Lin YL; Yin YJ; Liu H; Shu YN; Miao SB; Li H; Chen P; Han M
J Mol Med (Berl); 2015 May; 93(5):547-58. PubMed ID: 25515236
[TBL] [Abstract][Full Text] [Related]
20. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
